EUVIMEDEUVIMED entdecken
Fallbericht

A Case of AML1-ETO Positive Acute Myeloid Leukemia Morphologically Similar to Chronic Myelogenous Leukemia

Ruimin Li, Yiping Wu, Xiaofang Zhang, LihuaWang, Shuang Huo

Clinical Laboratory · 2023

DOI: 10.7754/clin.lab.2022.220914 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Laboratory, 2023. Verfasst von Ruimin Li und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The goal was to study the role of the morphology, immunophenotype, karyotype and fusion gene expression in a patient with diagnosis of AML1-ETO positive acute myeloid leukemia. METHODS: A case of AML1-ETO positive acute myeloid leukemia morphologically similar to chronic myelogenous leukemia was reported. The results of the morphology, immunophenotype, karyotype and fusion gene expression were analyzed by reviewing relevant literature. RESULTS: The patient was a young boy, at the age of 13, with clinical manifestations of intermittent fatigue and fever. Blood routine: White blood cell 142.6 x 109/L, Red blood cell 0.89 x 1012/L, Hemoglobin 41 g/L, Platelet 23 x 109/L, primitive cells account for 5%. Bone marrow smear: Granulocyte system hyperplasia is obvious, visible at each stage, primitive cells account for 17%, eosinophils, basophils, and phagocytic blood cells were observed. Flow cytometry showed myeloid primitive cell population was 4.14%, immature and mature granulocytes cell population was 85.22%, and eosinophil cell population was 0.61%. The results showed that the proportion of myeloid primitive cell was high, the expression of CD34 was enhanced, the expression of CD117 was partially absent, the expression of CD38 was weakened, the expression of CD19 was weak, and a few cells expressed CD56, and the phenotype was abnormal. The proportion of granulocyte series increased and the nucleus shifted to the left. The proportion of erythroid series was decreased, and the expression of CD71 was weakened. The results of fusion gene showed AML1-ETO positive. Karyotype analysis showed clonogenic abnormality t(8;21)(q22;q22). CONCLUSIONS: The peripheral blood and bone marrow images of patients with t(8;21)(q22;q22) AML1-ETO positive are the manifestations of chronic myelogenous leukemia, suggesting that cytogenetics and molecular genetics play an irreplaceable role in the diagnosis of acute myeloid leukemia, and the comprehensive diagnostic efficiency is significantly better than that of morphology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansRUNX1 Translocation Partner 1 ProteinCore Binding Factor Alpha 2 SubunitBone MarrowChronic DiseaseOncogene Proteins, FusionChromosomes, Human, Pair 8

Substanzen

RUNX1 Translocation Partner 1 ProteinCore Binding Factor Alpha 2 SubunitOncogene Proteins, FusionAML1-ETO fusion protein, human

Zitieren

APA

Li, R., Wu, Y., Zhang, X., LihuaWang, & Huo, S. (2023). A Case of AML1-ETO Positive Acute Myeloid Leukemia Morphologically Similar to Chronic Myelogenous Leukemia. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2022.220914

Vancouver

Li R, Wu Y, Zhang X, LihuaWang, Huo S. A Case of AML1-ETO Positive Acute Myeloid Leukemia Morphologically Similar to Chronic Myelogenous Leukemia. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2022.220914

BibTeX
@article{Li2023,
  author = {Li, Ruimin and Wu, Yiping and Zhang, Xiaofang and LihuaWang and Huo, Shuang},
  title = {A Case of AML1-ETO Positive Acute Myeloid Leukemia Morphologically Similar to Chronic Myelogenous Leukemia},
  journal = {Clinical Laboratory},
  year = {2023},
  doi = {10.7754/clin.lab.2022.220914}
}
Kostenlos starten →